Cite
HARVARD Citation
Sharma, S. et al. (2022). Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjects. British journal of clinical pharmacology. 88 (10), pp. 4573-4584. [Online].